Your browser doesn't support javascript.
loading
Strategies for single base gene editing in an immortalized human cell line by CRISPR/Cas9 technology.
Corrado, Alda; Aceto, Romina; Miglietta, Simona; Silvestri, Roberto; Dell'Anno, Irene; Lepori, Irene; Ricci, Benedetta; Romei, Cristina; Giovannoni, Roberto; Poliseno, Laura; Evangelista, Monica; Vitiello, Marianna; Cipollini, Monica; Elisei, Rossella; Landi, Stefano; Gemignani, Federica.
Afiliação
  • Corrado A; Department of Biology, Genetic Unit, University of Pisa, Via Derna 1, 56126 Pisa, Italy.
  • Aceto R; Department of Biology, Genetic Unit, University of Pisa, Via Derna 1, 56126 Pisa, Italy.
  • Miglietta S; Humanitas Clinical and Research Centre- IRCCS, Via Manzoni 56, 20089 Milan, Italy.
  • Silvestri R; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milan, Italy.
  • Dell'Anno I; Department of Biology, Genetic Unit, University of Pisa, Via Derna 1, 56126 Pisa, Italy.
  • Lepori I; Department of Biology, Genetic Unit, University of Pisa, Via Derna 1, 56126 Pisa, Italy.
  • Ricci B; Institute of Clinical Physiology (IFC), CNR, Via Giuseppe Moruzzi 1, 56124 Pisa, Italy.
  • Romei C; Fondazione I.R.C.C.S., Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.
  • Giovannoni R; Endocrine Unit, Department of Clinical and Experimental Medicine, University of Pisa, Via Paradisa 2, 56124 Pisa, Italy.
  • Poliseno L; Department of Biology, Genetic Unit, University of Pisa, Via Derna 1, 56126 Pisa, Italy.
  • Evangelista M; Institute of Clinical Physiology (IFC), CNR, Via Giuseppe Moruzzi 1, 56124 Pisa, Italy.
  • Vitiello M; Institute of Clinical Physiology (IFC), CNR, Via Giuseppe Moruzzi 1, 56124 Pisa, Italy.
  • Cipollini M; Institute of Clinical Physiology (IFC), CNR, Via Giuseppe Moruzzi 1, 56124 Pisa, Italy.
  • Elisei R; Department of Biology, Genetic Unit, University of Pisa, Via Derna 1, 56126 Pisa, Italy.
  • Landi S; Endocrine Unit, Department of Clinical and Experimental Medicine, University of Pisa, Via Paradisa 2, 56124 Pisa, Italy.
  • Gemignani F; Department of Biology, Genetic Unit, University of Pisa, Via Derna 1, 56126 Pisa, Italy.
3 Biotech ; 14(2): 45, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38261961
ABSTRACT
The use of CRISPR/Cas9 system has rapidly grown in the last years. Here, the optimization of gene editing of a single-nucleotide polymorphism in a human non-malignant somatic cell line of thyrocytes (Nthy-Ori) was described highlighting strategies for overcoming the problems concerning the delivery and off-targets. We employed both lentivirus and chemical lipids as delivery agents and two strategies for creating the double-strand breaks (DSB). The former induced a DSB by a classical Cas9 nuclease (standard strategy), while the second one employed a modified Cas9 creating a single-strand break (SSB). The knock-in was carried out using a single-stranded donor oligonucleotide or the HR410-PA donor vector (HR). The desired cells could be obtained by combining the double nickase system with the HR vector transfected chemically. This result could be due to the type of DSB, likely processed mainly by non-homologous end joining when blunt (standard strategy) and by HR when overhanging (double nickase). Our results showed that the double nickase is suitable for knocking-in the immortalized Nthy-Ori cell line, while the standard CRISPR/Cas9 system is suitable for gene knock-out creating in/del mutations. Supplementary Information The online version contains supplementary material available at 10.1007/s13205-023-03878-4.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article